Clinical Trial Update: Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer [Phase 3]

View source ↗

Summary

This Phase 3 trial focuses on identifying and treating micrometastatic disease in Stage III colon cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Metastatic Colon Cancer, Stage III Colon Cancer | Phase 3 | Status: RECRUITING